Want to see ADAPY full AI Analyst Report?
Adaptimmune Therapeutics Plc. ($ADAPY) announced an update on their ongoing clinical study. The study “AFPᶜ³³²T in Advanced HCC” from Adaptimmune is a Phase 1 trial in patients with advanced liver
...Read more
ADAPY News on the Web
TipRanks News
Neutral
AAII
Neutral
AAII
Neutral
AAII
Neutral
TipRanks News
Neutral
AAII
Neutral
rttnews
Neutral
rttnews
Neutral
News Score - Last 7 Days
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines Media Buzz and News Sentiment.
This score is generated using a formula that combines Media Buzz and News Sentiment.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is ADAPY’s Media Buzz Sentiment?
Currently, no data Available
What is ADAPY’s weekly average amount of articles?
In an average week, 0.25 articles about ADAPY are published.
What is ADAPY’s News Sentiment?
Currently, no data Available